Health
Maker seeking Indian trial of Novavax jab – Eyre Peninsula Tribune
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19…
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.
Serum expected a decision on an Indian trial of Novavax’s vaccine soon, Chief Executive Adar Poonawalla told Reuters on Friday, hours after the US company reported the efficacy data.
“We have already applied to the drug controller’s office for the bridging trial, a few days…
-
General19 hours agoVictorian school teacher charged with soliciting child abuse material
-
General10 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business14 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
Business22 hours agoEconomic roundtable or maturity test?